Rise in the chronic diseases and increase in the air pollution & air quality are some of the significant reasons to propel the growth of the acute respiratory distress syndrome market during the forecast years.
Market Size – USD 583.8 Million in 2018, Market Growth – CAGR of 6.0% for the year 2026, Market trends – Increasing lung injuries due to car accidents with various chronic diseases such as pulmonary or systemic infection, neurological conditions, among others.
According to the analysis of Reports and Data, the global acute respiratory distress syndrome market was valued at USD 583.8 Million in 2018 and is expected to reach USD 934.8 Million by the year 2026, at a CAGR of 6.0%. Acute respiratory distress syndrome (ARDS) is a type of respiratory failure, which is a form of lung inflammation. Due to which there is a problem with the proper delivery of the oxygen to the different body organs, which at the end impact the appropriate functioning of the parts. Various causes are included with the ARDS, such as sepsis, trauma, pneumonia, and others. The primary treatment for the ARDS involves mechanical ventilation, which is delivered through a rigid tube that enters the oral cavity and is secured in the airway.
According to a survey done by the World Health Organization (WHO), it is seen that more than 3 million people are effects due to acute respiratory distress syndrome. It can affect people of all ages. The main reason for the ARDS is air pollution, which is caused due to the emission by the vehicles. The harmful gases emitted are inhaled by the people thus leading to several problems.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2089
The rapid adoption of AI, ML, and IoT and robust data management processes has made the hospitals and clinical settings smarter. New technologies and solutions have improved the normal medical processes such as clinical diagnosis, treatment, diseases management, and monitoring patient recovery after discharge. Rapid digitalization and increasing adoption of virtual care and telemedicine is further expected to positively impact the revenue growth of the market going ahead.
Emergence of new healthcare and telemedicine startups, increasing number of collaborations among healthcare facilities and research institutions, and rising focus on patient engagement solutions has further fueled revenue growth of the market. Key companies are forming strategic alliances and collaborative ventures such as mergers and acquisitions, joint ventures, partnerships, manufacturing and licensing agreements, and product launches among others.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2089
Leading Players Analyzed in the Report:
Faron Pharmaceuticals, BioMarck Pharmaceuticals, GE Healthcare, Hamilton Medical AG, Smiths Medical, Athersys, GlaxoSmithKline, Altor Bioscience, and Mondobiotech
Furthermore, to offer a better understanding of the competitive landscape, an extensive SWOT analysis and Porter’s Five Forces analysis are included in the report. Along with this, feasibility analysis and investment return analysis are also covered in the report.
The report further discusses in detail the regional spread of the global Acute Respiratory Distress Syndrome (ARDS) market along with analysis of production and consumption patterns, import/export analysis, supply and demand ratio, market share and size based on volume and value, trends and demands, revenue share, and presence of the key players of the market.
To know more about the report @ https://www.reportsanddata.com/report-detail/acute-respiratory-distress-syndrome-ards-market
Key Regions Studied in the Report:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, France, Rest of Europe)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Device Type (Revenue in USD Million; Volume in Tons, 2016–2026)
- Monitoring Devices
- Diagnostic Devices
- Blood Gas Analyzers
- Pulse Oximeters
- Capnography Devices
- Other Diagnostic Devices
- Therapeutic Devices
- Mechanical Ventilators
- Invasive And Non-invasive Ventilators
- Drug Delivery Devices
- Other Therapeutic Devices
Injury Type (Revenue in USD Million; Volume in Tons, 2016–2026)
- Brain Injury
- Lung Injury
Severity (Revenue in USD Million; Volume in Tons, 2016–2026)
Treatment (Revenue in USD Million; Volume in Tons, 2016–2026)
- Fibro Proliferate
- Exudative Stage
- Resolution Stage
- Recovery Stage
Sales Channel (Revenue in USD Million; Volume in Tons, 2016–2026)
- Direct Sales
- Channel Sales
End User (Revenue in USD Million; Volume in Tons, 2016–2026)
- Ambulatory Service Centers
- Other End Users
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2089
Thank you for reading our report. To know more about the customization of the report or further query about the report, please get in touch with us. Our team will ensure the report is well suited to your requirements.
Browse More Reports:
Antibiotics Market Size @ https://www.biospace.com/article/antibiotics-market-to-reach-usd-68-37-billion-by-2028-reports-and-data/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.